1·OBJECTIVE: to study the stability of carboplatin suppository.
目的：对新研制的卡铂栓进行稳定性实验研究。
2·Objective:To investigate the toxicity of the large dose carboplatin.
目的：探讨大剂量卡铂化疗的安全性。
3·Methods Analysis of 33 cases of NSCLC treated by Taxol and Carboplatin.
方法对33例应用泰素加卡铂治疗的晚期非小细胞肺癌患者进行分析。
4·OBJECTIVE: To prepare biodegradable albumin microspheres containing carboplatin.
目的：制备可生物降解的卡铂白蛋白微球。
5·A key question raised by this patient is whether to use cisplatin or carboplatin.
这一患者带来的关键问题是用顺铂还是用卡铂。
6·In North America, this would usually be carboplatin and in Europe it would be cisplatin.
在北美常用卡铂，在欧洲则是顺铂。
7·Patients received six cycles of paclitaxel and carboplatin alone or the therapy cycles with ASA404.
这些病人单独或与ASA404一起接受了6个周期紫衫醇和卡铂的治疗。
8·It is indicated that the total levels of these complexes are not superior to Cisplatin and Carboplatin.
这些配合物的总体水平并不优于顺铂和卡铂。
9·Objective To observe the efficacy and side effects of carboplatin solution in comparison with carboplatin powder.
目的观察国产卡铂注射液的疗效及毒性，并与卡铂粉针剂比较。
10·Objective:To investigate the efficacy of treating taxol plus carboplatin in the treatment of non-small cell lung cancer.
目的：探讨泰素加卡铂联合化疗方案对非小细胞肺癌的疗效。